June 18 (Thu) June 19 (Fri) Download Scientific ProgramDownload Scientific ProgramDownload Scientific Program



Meet the Professor 07:30-08:20, Crystall Ballroom A,B,C
1:Role of an innovative medical oncologist in the management of cancer patients
Hoo Geun Chun (The Catholic University of Korea College of Medicine)
2:Minimally invasive surgery for colorectal cancer: the 2015 update on evidence
Seon-Hahn KIM (Korea University College of Medicine)
3:Role of surgical oncologist in gastric cancer research
Han-Kwang Yang (Seoul National University College of Medicine)
Educational Session 08:30-09:40
1:Innovative treatment in medical oncology Crystal Ballroom A
1) Innovative treatment of breast cancer
Kyong Hwa Park (Korea University College of Medicine)
2) Innovative treatment of sarcoma
Jin Hee Ahn (Asan Medical Center)
3) Innovative treatment of colon cancer
Sang-Cheol Lee (Soonchunhyang University College of Medicine)
2:Current status of brachytherapy in Korea Crystal Ballroom B
1) Current status of brachytherapy for gynecologic cancer in Korea
Yong Bae Kim (Yonsei University College of Medicine)
2) Recent improvement of brachytherapy in cervical cancer
Yeon-Joo Kim (National Cancer Center)
3) Current status of prostate brachytherapy in Korea
Jaeho Cho (Yonsei University College of Medicine)
3:Oncologic views of radical and limited LN dissection Crystal Ballroom C
1) Oncologic views of radical & limited lymph node dissection: colorectal cancer
Jung-Myun Kwak (Korea University College of Medicine)
2) Oncologic views of radical and limited LN dissection in breast cancer treatment
Jeong Eon Lee (Samsung Medical Center)
3) Determination for extent of LN dissection: Ongoing dilemma of gastric cancer surgery
Han Hong Lee (The Catholic University of Korea College of Medicine)
Young Investigator Symposium 08:30-09:40, Sapphire Ballroom B
1) Phase I trials as cancer therapy: clinical fellowship experience at MD Anderson Cancer Center
Yong Wha Moon (Yonsei University College of Medicine)
2) Role of aggressive debulking surgery in advanced ovarian cancer: Can surgical aggressiveness compensate for tumor biology?
Suk-Joon Chang (Ajou University School of Medicine)
3) Tumor heterogeneity in lung cancer
Sang-Won Um (Samsung Medical Center)
4) The methyltransferases EZH1 and EZH2 control hepatocyte homeostasis and regeneration
Woo Kyun Bae (Chonnam National University Medical School)
Plenary Lecture 1 (in English) 10:00-10:30, Crystal Ballroom
Dare to push the limit
Jin Soo Lee, M.D., Ph.D. (National Cancer Center)
Plenary Lecture 2 (in English) 10:30-11:20, Crystal Ballroom
Fundamental insights and translational opportunities arising from cancer epigenetics
Peter W. Laird, Ph.D. (Professor and Head, Center for Epigenetics, Van Andel Research Institute, USA)
Symposium 1 (in English) 12:40-14:20, Crystal Ballroom A
Gastric cancer
1) Genomic landscape of gastric cancer
Jae Yong Cho (Yonsei University College of Medicine)
2) Recent developments of targeted therapy in gastric cancer
Atsushi Ohtsu (National Cancer Center Hospital East, Japan)
3) Role of adjuvant/neo-adjuvant chemotherapy in locally advanced gastric cancer
Lin Shen (Peking University Cancer Hospital & Institute, China)
4) The use of exhaled breath test for the diagnosis and therapeutic monitoring of gastric cancer
George Hanna (Imperial College of London, UK)
Symposium 2 (in English) 12:40-14:20, Crystal Ballroom B
Epigenetics and cancer therapy
1) DNA Hypermethylome signature in human cancer for clinical use
Joo Mi Yi (Dongnam Institute of Radiological & Medical Sciences)
2) Identification of altered DNA methylation modulators in ovarian cancer cells with acquired cisplatin resistance
Yoon Jung Park (Ewha Womans University College of Health Science)
3) A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer
Jeong Hoon Kim (Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University)
4) Targeting chromatin remodeler for cancer radiotherapy
Jongbum Kwon (Ewha Womans University College of Natural Sciences)
Symposium 3 12:40-14:20, Crystal Ballroom C
Mitochondria energy metabloism
1) Identification of therapeutic target that links AMPK to WNT signaling in early-stage gastric cancer
Yon Hui Sarah Kim (National Cancer Center)
2) Mitochondrial chaperone TRAP1: structure, function, and inhibitors
Byoung Heon Kang (Ulsan National Institute of Science and Technology)
3) Post-transcriptional regulation of mitochondrial dynamics
Dong-Hyung Cho (Graduate School of East-West Medical Science, Kyung Hee University)
4) Apoptosis via mitochondria in epstein-barr virus transformed B cells
Dae Young Hur (Inje University College of Medicine)
Symposium 4 (in English) 12:40-14:20, Sapphire Ballroom B
Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute)
Novel strategies for anticancer therapy I
1) New insights into cellular origin of prostate epithelial development and tumorigenesis
Wei-Qiang Gao (Shanghai Cancer Institute, China)
2) Experimental therapeutic strategies for targeting HCC cancer stem cells
Jinjun Li (Shanghai Cancer Institute, China)
3) Different function of ARD1 variants in tumorigenesis
Kyu-Won Kim (Seoul National University College of Pharmacy)
4) Experience of next generation sequencing analysis of Korean breast cancer
Wonshik Han (Seoul National University College of Medicine)
Symposium 5 14:40-16:20, Crystal Ballroom A
Survivorship program and care plan
1) Primary care provider perspectives
Kyung Hyun Choi (Dongnam Institute of Radiological & Medical Sciences)
2) Nursing care provider perspectives
Soo Hyun Kim (Inha University College of Medicine)
3) Specialty care provider perspectives
Hye Yoon Park (Seoul National University College of Medicine)
4) Oncologist care provider perspectives
Dae Ho Lee (Asan Medical Center)
Symposium 6 (in English) 14:40-16:20, Crystal Ballroom B
Joint Symposium (Korean Cancer Association & Korean Genome Organization)
Next great leap of omics for personalized medicine in cancer
1) An integrative proteogenomics approach in gastric cancer
Daehee Hwang (Daegu Gyeongbuk Institute of Science & Technology)
2) Cooperation of driver mutations induces epithelial-to-mesenchymal transition in lung cancer
Hyun Seok Kim (Yonsei University College of Medicine)
3) Application of cancer genome anlaysis in clinical oncology
Yoon-La Choi (Samsung Medical Center)
4) Epigenetic control of gene expression dynamics
TaeSoo Kim (Ewha Womans University College of Natural Sciences)
Symposium 7 (in English) 14:40-16:20, Crystal Ballroom C
New treatment in cancer
1) Laparoscopic and function preserving cancer surgery : evidences in gastric cancer
Hyuk-Joon Lee (Seoul National University College of Medicine)
2) Review of carbon ion radiotherapy and current status of Korea Heavy-ion Medical Accelerator (KHIMA) project
Mi Sook Kim (Korea Institute of Radiological & Medical Sciences)
3) Targeted radionuclide therapy
So Won Oh (Seoul National University Boramae Medical Center)
Symposium 8 14:40-16:20, Sapphire Ballroom A
Joint Symposium (Korean Cancer Association & Korean Society of Nuclear Medicine)
Advence of radionuclide theranostics in oncology
1) Radionuclide theranostics in radioiodine-refractory thyroid cancer
Byeong-Cheol Ahn (Kyungpook National University School of Medicine)
2) Radioembolization in hepatocellular carcinoma
Jae-Gol Choe (Korea University College of Medicine)
3) I-131 rituximab radioimmunotherapy in B cell lymphoma
Sang-Moo Lim (Korea Institute of Radiological & Medical Sciences)
Symposium 9 (in English) 14:40-16:20, Sapphire Ballroom B
Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute)
Novel strategies for anticancer therapy II
1) Novel concept for cancer targeted therapy
Zonghai Li (Shanghai Cancer Institute, China)
2) Regulation of Warburg effect by hormone receptors in hepatocellular carcinoma
Zhigang Zhang (Shanghai Cancer Institute, China)
3) Stromal stem-like cells for maintenance of infiltrative property in human glioblastoma
Su-Jae Lee (Hanyang University College of Natural Sciences)
4) Hypoxia induces angiogenic miRs targeting tumour suppressors
You Mie Lee (Kyungpook National University College of Pharmacy)
Satellite Symposium 1 (in English) 11:30-12:20, Crystal Ballroom
A decade of anti-angiogenic therapy: past, present and future (by Roche)
Yeul Hong Kim (Korea University College of Medicine)
Satellite Symposium 2 (in English) 11:30-12:20, Sapphire Ballroom
Emerging role of immunotherapy (by MSD)
Kenneth O'Byrne (Princess Alexandra Hospital, Australia)
Satellite Symposium 3 (in English) 18:00~19:00, Crystal Ballroom A
New Treatment in ALK+ Lung Cancer (by Novartis)
Dong-Wan Kim (Seoul National University College of Medicine)
Satellite Symposium 4 (in English) 18:00~20:00, Crystal Ballroom B
'Bayer Korea Oncology Symposium
I. GI cancer
1) Colorectal Cancer-The role of targeted therapies in the strategy of mCRC treatment
Salvatore Siena (Niguarda Ca' Granda, Milan, Italy)
2) Gastric cancer- Revisit of antiangiogenesis strategy in gastric cancer
Do-Youn Oh (Seoul National University College of Medicine)
II. Cancer cell signaling and metabolism
1) How to address new targets in oncology
Dirk Laurent (Bayer, USA)
2) Research experience for biomarker development in cancer treatment
Sun Young Rha (Yonsei University College of Medicine)
Oral Presentation 1 12:40-13:30, Sapphire Ballroom A
Oral Presentation 2 13:30-14:20, Sapphire Ballroom A
Oral Presentation 3 16:20-17:40, Crystall Ballroom A
Oral Presentation 4 16:20-17:40, Crystall Ballroom B
Oral Presentation 5 16:20-17:40, Crystall Ballroom C
International Session 1 (Oral, in English) 16:20-17:40, Sapphire Ballroom A
International Session 2 (Oral, in English) 16:20-17:40, Sapphire Ballroom B
Poster Presentation 09:00~17:00, Emerald Room